Cytoskeletal Proteins in Cancer and Intracellular Stress: A Therapeutic Perspective

Mei Shan Ong1, Shuo Deng1, Clarissa Esmeralda Halim1

  • 1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117593 Singapore, Singapore.

Cancers
|January 23, 2020
PubMed

Insights

Cytoskeletal proteins are vital for cell function but are altered in cancer cells to promote tumor growth and spread. Targeting these altered cytoskeletal proteins offers new therapeutic strategies for cancer progression.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Cytoskeletal proteins (microtubules, actin, intermediate filaments) are crucial for normal cellular functions.
  • In cancer, cytoskeletal protein functions are dysregulated, enhancing tumor development, migration, invasion, proliferation, and stress resistance.

Purpose of the Study:

  • To discuss cytoskeletal responses to intracellular stresses (mitochondrial, ER, oxidative).
  • To delineate the consequences of these responses on oncogenic signaling.
  • To explore cytoskeletal proteins as therapeutic targets for novel cancer progression strategies.

Main Methods:

  • Literature review and discussion of existing research on cytoskeletal proteins in cancer.
  • Analysis of cytoskeletal responses to intracellular stresses.
  • Exploration of therapeutic targeting strategies for cytoskeletal proteins.

Main Results:

  • Altered cytoskeletal mechanisms in cancer cells promote tumor progression and metastasis.
  • Cytoskeletal responses to stress impact oncogenic signaling pathways.
  • Cytoskeletal proteins and associated molecules represent viable therapeutic targets.

Conclusions:

  • Understanding cytoskeletal adaptations to stress is key to developing effective cancer therapies.
  • Targeting novel cytoskeletal proteins holds potential for impacting cancer progression, despite limitations.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K